CCM
NDRM

Cadian Capital Management’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Cadian Capital Management’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-419,315
Closed -$8.67M – 126
2015
Q3 		$8.67M Buy
+419,315
New +$8.6M 0.31% 58

Other funds holding NDRM

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Cadian Capital Management's NDRM Position: Q4 2015 in Review

Cadian Capital Management sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2015, closing a stake of 419,315 shares — an estimated $8.67M sold.

Cadian Capital Management first reported a position in NDRM in Q3 2015 and held it in 1 quarter. The position peaked at $8.67M in Q3 2015. 49 funds tracked by Wall St. Rank hold NDRM as of Q4 2015.

  • Cadian Capital Management reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2015 after selling out during the quarter.
  • Cadian Capital Management sold 419,315 NeuroDerm Ltd. Ordinary Shares shares in Q4 2015, an estimated $8.67M.
  • Cadian Capital Management first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2015 and held it in 1 quarter.
  • Cadian Capital Management's NeuroDerm Ltd. Ordinary Shares position peaked at $8.67M in Q3 2015.
  • 49 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2015.

Based on Cadian Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.